These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1344678)

  • 1. The inspection of drug metabolism and pharmacokinetic studies.
    Dent NJ
    Qual Assur; 1992 Jun; 1(3):230-6. PubMed ID: 1344678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auditing drug metabolism protocols, data, and reports.
    Lucas G; Walls S
    Qual Assur; 1994 Jun; 3(2):193-7. PubMed ID: 7804636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying the Good Laboratory Practice regulations to studies involving genetically modified plants.
    Holden DE
    Qual Assur; 1995 Dec; 4(4):361-5. PubMed ID: 8890368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EPA's GLP compliance review of chemistry laboratories.
    Hill DF
    Qual Assur; 1993; 2(1-2):78-84. PubMed ID: 8156226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Auditing metabolism studies: a scientist's perspective.
    Nadeau RG
    Qual Assur; 1995 Dec; 4(4):351-7. PubMed ID: 8890366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A procedure for assessing a contract testing facility: one sponsor's perspective.
    Twitty MM; Martin SA; Henry JL; Nowicki LJ; Dabrowski MJ; Veresh LM
    Qual Assur; 1997; 5(1):61-8. PubMed ID: 9170176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical aspects of conducting and auditing GLP studies--the practical perspective.
    Pejovich RJ
    Qual Assur; 1995 Mar; 4(1):87-90. PubMed ID: 8520871
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of pharmacokinetics as an interpretive and predictive tool in chemical toxicology testing and risk assessment: a position paper on the appropriate use of pharmacokinetics in chemical toxicology.
    Frantz SW; Beatty PW; English JC; Hundley SG; Wilson AG
    Regul Toxicol Pharmacol; 1994 Jun; 19(3):317-37. PubMed ID: 8090955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemical compound safety: typology of competency accreditation for assay centers and analytical laboratories].
    Menditto A; Chiodo F
    Ann Ist Super Sanita; 2002; 38(1):77-85. PubMed ID: 12122899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Continuous challenges in Japanese forensic toxicology practice: strategy to address specific goals].
    Kageura M
    Nihon Hoigaku Zasshi; 2002 Sep; 56(2-3):219-28. PubMed ID: 12415829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety pharmacology: an essential interface of pharmacology and toxicology in the non-clinical assessment of new pharmaceuticals.
    Claude JR; Claude N
    Toxicol Lett; 2004 Jun; 151(1):25-8. PubMed ID: 15177637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA audit of nonclinical studies.
    Horowitz AM
    Qual Assur; 1995 Sep; 4(3):227-38. PubMed ID: 8705117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. U.S. EPA challenges and review--highlights of the Fiscal Year 1994 Inspection Program and EPA's laboratory accreditation considerations.
    Dull D
    Qual Assur; 1995 Mar; 4(1):20-8. PubMed ID: 8520861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer validation vendor audits.
    Looney DM
    Qual Assur; 1994 Mar; 3(1):22-6. PubMed ID: 7804615
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacokinetic and metabolic studies in the development of drugs].
    Vereczkey L
    Acta Pharm Hung; 1995 Jul; 65(4):105-11. PubMed ID: 7572191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performing laboratory compliance audits.
    Keoppel P
    Clin Leadersh Manag Rev; 2001; 15(6):368-75. PubMed ID: 11822264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiolabeled absorption, distribution, metabolism, and excretion studies in drug development: why, when, and how?
    Penner N; Xu L; Prakash C
    Chem Res Toxicol; 2012 Mar; 25(3):513-31. PubMed ID: 22309195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facility capability assessment.
    McCandless J
    Qual Assur; 1994 Jun; 3(2):156-66. PubMed ID: 7804631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Pathology Laboratory Act 2007 explained.
    Looi LM
    Malays J Pathol; 2008 Jun; 30(1):1-10. PubMed ID: 19108405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical auditing of toxicology reports.
    Deaton RR; Obenchain RL
    Qual Assur; 1994 Jun; 3(2):189-92. PubMed ID: 7804635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.